{"id":734,"date":"2017-06-30T16:27:49","date_gmt":"2017-06-30T10:57:49","guid":{"rendered":"https:\/\/babrone.avfu.ac.in\/blog\/?p=734"},"modified":"2018-11-10T13:35:38","modified_gmt":"2018-11-10T08:05:38","slug":"bacterial-ghost-a-tool-for-vaccine-delivery","status":"publish","type":"post","link":"https:\/\/babrone.avfu.ac.in\/blog\/?p=734","title":{"rendered":"Bacterial Ghost: A Tool for Vaccine Delivery"},"content":{"rendered":"<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Lytic bacteriophages induce bacterial cell lysis to release progeny virions from their host cells at the last stage of the lytic cycle. Thus, the bacteriophages have developed several strategies degrading peptidoglycan layers (PGs) which are a major component of bacterial cell walls. For instance, a single lysis gene<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">&nbsp;<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>E<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">&nbsp;<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">of bacteriophage \u03a6X-174 inhibits murein biosynthesis, and then oligomerizes proteinaceous channels in the cell envelope. Demonstration of the capacity of protein E to effectively inactivate Gram-negative bacteria led to generate genetically inactivated vaccine constructs known as <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>bacterial ghosts<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> (BGs). BGs are empty cell envelopes of Gram-negative bacteria, which have excellent adjuvant and vaccine delivery system properties. BG generated by \u03a6X174 lysis gene<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">&nbsp;<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>E<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">&nbsp;<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">preserves an intact cell envelope structures containing the potential pathogenic traits of the bacteria, which<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> has <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">the capacity to induce local immunities. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Bacterial ghost are non-living gram-negative bacterial cell envelope devoid of cytoplasmic contents, and maintaining their cellular morphology and the surface antigenic structures including their bio-adhesive properties (Won <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2017). <\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>Production of Bacterial Ghost<\/b><\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Bacterial ghosts are produced by expression of cloned gene E from bacteriophage PhiX174 resulting in cell lysis in Gram-negative bacteria. Lysis gene E codes for a protein of 91 amino acids and exerts its lytic function in Gram-negative bacteria by the fusion of inner and outer membranes, and transmembrane tunnel formation. Through this tunnel, cytoplasmic content of the bacteria is expelled leaving an empty internal space devoid of the bacterial nucleic acids, ribosomes and other higher or lower lipoproteins, proteins, lipopolysaccharides, DNA and molecular weight constituents, whereas the inner and outer membrane structures are preserved.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><img loading=\"lazy\" decoding=\"async\" class=\"alignleft size-medium wp-image-743\" src=\"https:\/\/babrone.avfu.ac.in\/blog\/wp-content\/uploads\/2017\/06\/bacterialGhost-inArticle-300x182.gif\" alt=\"bacterialGhost-inArticle\" width=\"300\" height=\"182\" srcset=\"https:\/\/babrone.avfu.ac.in\/blog\/wp-content\/uploads\/2017\/06\/bacterialGhost-inArticle-300x182.gif 300w, https:\/\/babrone.avfu.ac.in\/blog\/wp-content\/uploads\/2017\/06\/bacterialGhost-inArticle-148x90.gif 148w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The driving force for the release of cytoplasmic material is the pressure difference between the cytoplasm and the medium created by the opening of the tunnel structure. The current working model of E-mediated lysis divides the process into three phases: Phase 1-: characterized by integration of protein E into the inner membrane, Phase 2-: initiated by a conformational change of protein E transferring its C-terminus across the inner membrane, and Phase 3-: a local fusion of C-terminal domain of protein E towards the surface of the outer membrane of the bacterium<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> (Michael <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 1996)<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"font-family: 'Times New Roman', serif; color: #000000;\"><span style=\"font-size: medium;\"><b>Working mechanism<\/b><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">One of the major issues in vaccine designing is finding a safe method to introduce the immunogenic part of the pathogen to the host\u2019s immune system. Besides the safety of the delivery system, it should also be able to present the antigen to the cells of the immune system. Recently, bacterial ghost technology has attracted the attention of vaccine designers, as it has both of these imperative characteristics: safety and efficacy (Jalava <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2002).<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"font-family: 'Times New Roman', serif; color: #000000;\"><span style=\"font-size: medium;\">The key point of using BGs is the especial intact proteins and other pathogen-related compartments on the surface which stimulate immune cells to engulf them immediately when some drugs or a part of another pathogen (e.g. antigen from HIV or influenza virus) are put inside these cell walls or present the desired antigen on the surface of BGs. Immune cells engulf the cell wall which contains some other elements, either inside or at the surface. By this way, direct transfer of target antigen, DNA or drug into the host\u2019s immune cells is possible. Besides the efficient way of delivery, these empty cell walls boost the immune response against the target antigen because of their intrinsic pathogenic characteristics (Langemann<i> et al., <\/i>2010).<\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"font-family: 'Times New Roman', serif; color: #000000;\"><span style=\"font-size: medium;\">Several types of vaccines are being researched based on BG technology including vaccines against influenza, HIV,&nbsp;<em>Salmonella<\/em>&nbsp;and&nbsp;<em>E.coli<\/em>.<\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"font-family: 'Times New Roman', serif; color: #000000;\"><span style=\"font-size: medium;\"><b>Application in veterinary field<\/b><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The application of new strategies to develop vaccine is essential in modern veterinary medicine. The bacterial ghost system is a novel vaccine delivery system endowed with adjuvant properties Pigs parenterally immunized with <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Actinobacillus<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>pleuroneumoniae <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">ghosts were protected against both clinical disease and colonization after challenge. In<\/span><\/span><i> <\/i><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">contrast, parenteral immunization with formalin inactivated bacteria prevented the clinical disease but colonization after challenge was detected. Ghost-vaccinated pigs had a significantly greater antibody titer to a 100-kDa protein than infected convalescent pigs (Huter <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2000)<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Rabbits and mice were immunized with both <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Pasteurella multocida <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">and <\/span><\/span><em><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Mannheimia<\/span><\/span><\/em><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i> haemolytica <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">ghosts<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>. <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">In rabbit, both specific antibodies to the immunization strain were observed as well as a high degree of cross-reactivity to different serotypes and field isolates of <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Pasteurella<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> strains were detected (Marchrart <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2001).<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Bacterial ghosts derived from <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>E<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>coli <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">O78:K80 strains were prepared and day old chicks were immunized by intramuscular, oral and intranasal routes<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> (Chaudhari <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2002)<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. The prospects of Klebsiella pneumonia derived ghosts have been studied and piglets have been immunized with various doses of <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>K<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>pneumoniae <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Kpn-3 ghosts with two booster immunizations. The sera from Kpn-3 ghost vaccinated piglets also showed reactivity against human <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>K<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>pneumoniae <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">strain A565 indicating cross protective immunity with other serotypes (Marchrart <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2001).<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Salmonella <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Enteritidis (<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>S. <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Enteritidis) ghost are promising vaccine candidates because of their immunogenic and enhanced biosafety potential (Kamble <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">2016). <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Salmonella <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">typhimurium-based live bacterial vaccine vectors (LBV) exhibited not only the efficient delivery of an adjuvant protein, adhesin and toxin antigens for progressive atrophic rhinitis from an<\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Asd<\/span><\/span><span style=\"font-size: xx-small;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">+<\/span><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">plasmid but also showed the significant enhancement of immune response in animal models. The LBVs based on <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>S. <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Typhimurium can be employed for the delivery of the immunogenic HA1 protein of the influenza virus. The HA1 protein of the influ\u001fenza virus is a proteolytically cleaved subunit of the hemagglutinin (HA) integral membrane protein. The HA1 subunit is responsible for the binding of the influenza virus to host cell receptors and is also the principal target for pro\u001ftective immune responses in humans and ani\u001fmals<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> (Kamble <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2017)<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>Recombinant Bacterial Ghosts<\/b><\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The extended recombinant ghost system is currently evaluated to combining as many as possible candidate vaccines which are stable without the requirement of a cold chain and do not need any adjuvant. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">For the production of a combination of vaccines against bacterial and viral pathogens or the use of bacterial ghosts as carrier systems for other antigens, a membrane targeting system was developed for the attachment of foreign protein entities to the inner side of the cytoplasmic membrane. By cloning the foreign DNA sequences into the<\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">membrane targeting vector, any gene of interest can be expressed as a hybrid protein with N-, C- or N-\/C terminal membrane anchors directing and attaching the fusion protein to the envelope complex of the bacteria prior to E-mediated lysis.<\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">The membrane-anchored target antigens carried by recombinant ghosts induced humoral as well as a cellular immune responses in animal models. It has been further emphasized that the system of membrane anchoring is not limited by the size of the foreign protein moieties attached to the inside of the inner membrane and that combinations of different antigens to be anchored are possible (Jaleta <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>et al.,<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> 2015).<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>Conclusion<\/b><\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\"><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">In spite of the exponential rate of discovery of new vaccines resulting from modern molecular biology, the lack of effective delivery technology is a major limiting factor in their application. Bacterial ghosts are very useful non-living carriers as they can carry foreign antigens, nucleic acid and drugs in one or more cellular locations. Their ease of manufacture and the fact that they can be stored and processed without the need for refrigeration and their excellent safety profile-even when administered at high doses-are important considerations for a broad path towards the optimal vaccine development. The identical surface receptors of the bacterial ghost and their living counterparts are being exploited for specific cellular and tissue targeting. Bacterial Ghost is a new technology which has tremendous potential in application as delivery system for vaccines, drugs and nucleic acids, but it needs more work and further investigations before being commercially exploited in a large scale in future.<\/span><\/span><\/span><\/p>\n<p align=\"JUSTIFY\">&nbsp;<\/p>\n<p align=\"JUSTIFY\"><span style=\"font-family: 'Times New Roman', serif; color: #000000;\"><span style=\"font-size: medium;\"><b>References:<\/b><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Chaudhari A., Jawale C.&nbsp;V., Kim S.&nbsp;W.&nbsp;&nbsp;and Lee. J.&nbsp;H.&nbsp; (2012).<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> Construction of a&nbsp;<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Salmonella<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">&nbsp;Gallinarum ghost as a novel inactivated vaccine candidate and its protective efficacy against fowl typhoid in chickens. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Veterinary Research<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><b>43<\/b><\/span><span style=\"font-family: 'Times New Roman', serif;\">:44. DOI:&nbsp;10.1186\/1297-9716-43-44.<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Huter V., Hensel A., Brand E., and Lubitz W. (2000). Improved protection against lung colonization by <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Actinobacillus pleuroneumoniae <\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">ghosts: characterization of a genetically inactivated vaccine, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>J. Biotechnol<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>83<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">: 161\u2013172.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Huter V., Szostak M.P., Gampfer J., Prethaler S., Wanner G. (1999). Bacterial ghosts as drug carrier and targeting vehicles<\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>, J. Control. Release<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>61<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">:51\u201363.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Jalava K., Hensel A., Szostak M., Resch S. and Lubitz W. (2002). Bacterial ghosts as vaccine candidates for veterinary applications. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>J Control Release<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>85<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">:17\u201325.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Jaleta H., Mamo B. and Disassa H. (2015). Review on Bacterial Ghost and its Application. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>International Journal of Microbiological Research<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>6<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> (3): 200-210.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\">Kamble N. M., Hyoung K. J.<\/span> <span style=\"font-family: 'Times New Roman', serif;\">and Lee J. H<\/span><span style=\"font-size: xx-small;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">. (2017).<\/span><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"> Live-attenuated auxotrophic mutant of <\/span><span style=\"font-family: 'Times New Roman', serif;\"><i>Salmonella<\/i><\/span><span style=\"font-family: 'Times New Roman', serif;\"> Typhimurium expressing immunogenic HA1 protein enhances immunity and protective efficacy against H1N1 influenza virus infection. <\/span><span style=\"font-family: 'Times New Roman', serif;\"><i>Future Microbiol<\/i><\/span><span style=\"font-family: 'Times New Roman', serif;\">. 10.2217\/fmb-2016-0190.<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Kamble N. M., Jawale C. V.<\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">and Lee J. H. (2016). <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Activation of chicken bone marrow-derived dendritic cells induced by a <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Salmonella<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> Enteritidis ghost vaccine candidate.<\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Poultry Science<\/i><\/span><\/span> <span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>10<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">:1\u20137 <\/span><\/span><a style=\"color: #000000;\" href=\"http:\/\/dx.doi.org\/10.3382\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">http:\/\/dx.doi.org\/10.3382<\/span><\/span><\/a><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-size: medium;\">Langemann T, Koller VJ, Muhammad A, Kudela P, Mayr UB, Lubitz W. (2010). The bacterial ghost platform system: Production and applications.&nbsp;<\/span><em><span style=\"font-size: medium;\">Bioengineered Bugs<\/span><\/em><span style=\"font-size: medium;\">. 1(5):326-336. doi:10.4161\/bbug.1.5.12540.<\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Marchrart J. (2001). <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Pasteurella<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"> combination vaccines, Ph.D. Thesis, University of Vienna, Austria.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">Michael P., Szostak P., Andreas H., Francis O., Eko F.O., Reinhard K., Tatjana, Horst M., Alexander H., Sebastian B., Gerhard W. and Werner L. (1996). Bacterial ghosts: non-living candidate vaccine. <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><i>Journal of Biotechnology<\/i><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">, <\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\"><b>44<\/b><\/span><\/span><span style=\"font-family: 'Times New Roman', serif;\"><span style=\"font-size: medium;\">(1-3): 161-170.<\/span><\/span><\/span><\/p>\n<p><span style=\"color: #000000;\"><a style=\"color: #000000;\" href=\"#auth-1\"><span style=\"font-size: medium;\">Won<\/span><\/a> <span style=\"font-size: medium;\">G.,<\/span> <span style=\"font-size: medium;\">Hajam I. A. and Lee J.H. (2017). Improved lysis efficiency and immunogenicity of<\/span><span style=\"font-size: medium;\">&nbsp;<\/span><span style=\"font-size: medium;\"><i>Salmonella<\/i><\/span><span style=\"font-size: medium;\">&nbsp;<\/span><span style=\"font-size: medium;\">ghosts mediated by co-expression of \u03bb phage holin-endolysin and \u0278X174 gene<\/span><span style=\"font-size: medium;\">&nbsp;<\/span><span style=\"font-size: medium;\"><i>E<\/i><\/span><span style=\"font-size: medium;\">. <\/span><span style=\"font-size: medium;\"><i>Scientific Reports<\/i><\/span><span style=\"font-size: medium;\"> doi:10.1038\/srep45139.<\/span><\/span><\/p>\n<p>&nbsp;<\/p>\n<pre><span style=\"color: #000000;\"><strong>Rupam Dutta<\/strong><\/span>\r\n<span style=\"color: #000000;\">Research Associate,<\/span>\r\n<span style=\"color: #000000;\">Dept. of Animal Biotechnology,<\/span>\r\n<span style=\"color: #000000;\">College of Veterinary Science,<\/span>\r\n<span style=\"color: #000000;\">Khanapara, Guwahati-22.<\/span><\/pre>\n<p class=\"western\" align=\"JUSTIFY\">&nbsp;<\/p>\n<p class=\"western\" align=\"JUSTIFY\">&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Lytic bacteriophages induce bacterial cell lysis to release progeny virions from their host cells at the last stage of the lytic cycle. Thus, the bacteriophages have developed several strategies degrading peptidoglycan layers (PGs) which are a major component of bacterial cell walls. For instance, a single lysis gene&nbsp;E&nbsp;of bacteriophage \u03a6X-174 inhibits murein biosynthesis, and then&#8230;<\/p>\n","protected":false},"author":1,"featured_media":737,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"ngg_post_thumbnail":0,"footnotes":""},"categories":[1,147],"tags":[71,72,73],"class_list":["post-734","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-articles","category-articlesthird-issue","tag-bacterial-ghosts","tag-bg","tag-cloned-gene"],"_links":{"self":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/734","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=734"}],"version-history":[{"count":4,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/734\/revisions"}],"predecessor-version":[{"id":744,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/posts\/734\/revisions\/744"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=\/wp\/v2\/media\/737"}],"wp:attachment":[{"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=734"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=734"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/babrone.avfu.ac.in\/blog\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=734"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}